Skip to main content
Top
Published in: BMC Public Health 1/2024

Open Access 01-12-2024 | Research

Assessing the price levels of medical service and influential factors: evidence from China

Authors: Yanxian Lin, Luo Li, Bao Liu

Published in: BMC Public Health | Issue 1/2024

Login to get access

Abstract

Background

Medical service prices play a crucial role in cost containment in China. This study aimed to assess the change in medical service price levels at the macro level and the relationship with relevant macroeconomic factors.

Methods

Data from the 2022 China Statistics Yearbook, the 2022 China Health Statistics Yearbook, and the 2020 China National Health Accounts Report were used. Time trends of health price levels, utilization, and health expenditure were examined. A time-series regression model was employed to measure the impact of service utilization and medical service prices on total medical service expenditure growth from 2000 to 2021. The Johansen cointegration test was conducted to test the cointegrating relationship between medical service price levels and total medical service expenditure, average wage of employees and CPI. The Granger causality test was performed to observe the direction of causality.

Results

Descriptive analyses showed consistent growth in utilization and medical service price levels from 2000 to 2021. The time-series model indicated that medical service expenditure was influenced by the rise in inpatient admissions and price levels of medical service and medicine. The Johansen cointegration test identified a long-term equilibrium relationship between medical service price levels and total medical service expenditure, average wage and CPI. The change in medical service price levels was the Granger cause of the change in medical service expenditure, but it had no impact on average wage and CPI. However, the change in medical service price levels was influenced by these three macroeconomic factors.

Conclusions

The growth of medical service expenditure in China was driven by inpatient use and price level. There was a long-term equilibrium relationship between medical service price levels and relevant macroeconomic factors. However, medical service price levels only affected medical service expenditure and have no impact on average wage and CPI. It is necessary to improve the value transmission mechanism of medical service prices.
Literature
1.
go back to reference Pammolli F, Riccaboni M, Magazzini L. The sustainability of European health care systems: beyond income and aging. Eur J Health Econ. 2012;13(5):623–34.CrossRefPubMed Pammolli F, Riccaboni M, Magazzini L. The sustainability of European health care systems: beyond income and aging. Eur J Health Econ. 2012;13(5):623–34.CrossRefPubMed
2.
go back to reference Dieleman JL, Squires E, Bui AL, Campbell M, Chapin A, Hamavid H, et al. Factors Associated With increases in US Health Care spending, 1996–2013. Jama-Journal of the American Medical Association. 2017;318(17):1668–78.CrossRef Dieleman JL, Squires E, Bui AL, Campbell M, Chapin A, Hamavid H, et al. Factors Associated With increases in US Health Care spending, 1996–2013. Jama-Journal of the American Medical Association. 2017;318(17):1668–78.CrossRef
3.
go back to reference Yan X, Liu Y, Rao K, Li J. What is the major driver of China’s hospital medical expenditure growth? A decomposing analysis. BMJ Open. 2022;12(2):e048308.CrossRefPubMedPubMedCentral Yan X, Liu Y, Rao K, Li J. What is the major driver of China’s hospital medical expenditure growth? A decomposing analysis. BMJ Open. 2022;12(2):e048308.CrossRefPubMedPubMedCentral
4.
go back to reference Huang T-Y, Togun A, Boese T, Dowd BE. Anal Afford Health Care Med Care. 2022;60(9):718–25. Huang T-Y, Togun A, Boese T, Dowd BE. Anal Afford Health Care Med Care. 2022;60(9):718–25.
5.
go back to reference Anderson GF, Hussey P, Petrosyan V. It’s still the prices, stupid: why the US spends so much on Health Care, and a tribute to Uwe Reinhardt. Health Aff. 2019;38(1):87–95.CrossRef Anderson GF, Hussey P, Petrosyan V. It’s still the prices, stupid: why the US spends so much on Health Care, and a tribute to Uwe Reinhardt. Health Aff. 2019;38(1):87–95.CrossRef
6.
go back to reference Papanicolas I, Woskie LR, Jha AK. Health Care Spending in the United States and Other High-Income Countries. JAMA. 2018;319(10):1024–39.CrossRefPubMed Papanicolas I, Woskie LR, Jha AK. Health Care Spending in the United States and Other High-Income Countries. JAMA. 2018;319(10):1024–39.CrossRefPubMed
7.
go back to reference Hartman M, Martin AB, Espinosa N, Catlin A, Natl Hlth Expenditure A. National Health Care spending in 2016: spending and enrollment growth slow after initial Coverage expansions. Health Aff. 2018;37(1):150–60.CrossRef Hartman M, Martin AB, Espinosa N, Catlin A, Natl Hlth Expenditure A. National Health Care spending in 2016: spending and enrollment growth slow after initial Coverage expansions. Health Aff. 2018;37(1):150–60.CrossRef
8.
go back to reference Stadhouders N, Kruse F, Tanke M, Koolman X, Jeurissen P. Effective healthcare cost-containment policies: a systematic review. Health Policy. 2019;123(1):71–9.CrossRefPubMed Stadhouders N, Kruse F, Tanke M, Koolman X, Jeurissen P. Effective healthcare cost-containment policies: a systematic review. Health Policy. 2019;123(1):71–9.CrossRefPubMed
10.
go back to reference Yip W, Fu H, Chen AT, Zhai T, Jian W, Xu R, et al. 10 years of health-care reform in China: progress and gaps in Universal Health Coverage. Lancet. 2019;394(10204):1192–204.CrossRefPubMed Yip W, Fu H, Chen AT, Zhai T, Jian W, Xu R, et al. 10 years of health-care reform in China: progress and gaps in Universal Health Coverage. Lancet. 2019;394(10204):1192–204.CrossRefPubMed
11.
go back to reference Pan J, Zhao H, Wang X, Shi X. Assessing spatial access to public and private hospitals in Sichuan, China: the influence of the private sector on the healthcare geography in China. Soc Sci Med. 2016;170:35–45.CrossRefPubMed Pan J, Zhao H, Wang X, Shi X. Assessing spatial access to public and private hospitals in Sichuan, China: the influence of the private sector on the healthcare geography in China. Soc Sci Med. 2016;170:35–45.CrossRefPubMed
12.
go back to reference Liu XZ, Liu YL, Chen NS. The Chinese experience of hospital price regulation. Health Policy Plann. 2000;15(2):157–63.CrossRef Liu XZ, Liu YL, Chen NS. The Chinese experience of hospital price regulation. Health Policy Plann. 2000;15(2):157–63.CrossRef
13.
go back to reference Sun Q, Santoro MA, Meng Q, Liu C, Eggleston K. Pharmaceutical policy in China. Health Aff. 2008;27(4):1042–50.CrossRef Sun Q, Santoro MA, Meng Q, Liu C, Eggleston K. Pharmaceutical policy in China. Health Aff. 2008;27(4):1042–50.CrossRef
14.
go back to reference Eggleston K, Ling L, Meng Q, Lindelow M, Wagstaff A. Health service delivery in China: a literature review. Health Econ. 2008;17(2):149–65.CrossRefPubMed Eggleston K, Ling L, Meng Q, Lindelow M, Wagstaff A. Health service delivery in China: a literature review. Health Econ. 2008;17(2):149–65.CrossRefPubMed
15.
go back to reference Wang Y, Zhang Y, Ma C, Jiang Y, Li Y, Wang X, et al. Limited effects of the comprehensive pricing healthcare reform in China. Public Health. 2019;175:4–7.CrossRefPubMed Wang Y, Zhang Y, Ma C, Jiang Y, Li Y, Wang X, et al. Limited effects of the comprehensive pricing healthcare reform in China. Public Health. 2019;175:4–7.CrossRefPubMed
16.
go back to reference Zhou M, Zhao S, Fu M. Supply-induced demand for medical services under price regulation: evidence from hospital expansion in China. China Econ Rev. 2021;68. Zhou M, Zhao S, Fu M. Supply-induced demand for medical services under price regulation: evidence from hospital expansion in China. China Econ Rev. 2021;68.
17.
go back to reference Xiong W, Deng Y, Yang Y, Zhang Y, Pan J. Assessment of Medical Service Pricing in China’s Healthcare System: Challenges, Constraints, and Policy Recommendations. Front Public Health. 2021;9. Xiong W, Deng Y, Yang Y, Zhang Y, Pan J. Assessment of Medical Service Pricing in China’s Healthcare System: Challenges, Constraints, and Policy Recommendations. Front Public Health. 2021;9.
19.
go back to reference Fu H, Li L, Yip W. Intended and unintended impacts of price changes for drugs and medical services: evidence from China. Soc Sci Med. 2018;211:114–22.CrossRefPubMed Fu H, Li L, Yip W. Intended and unintended impacts of price changes for drugs and medical services: evidence from China. Soc Sci Med. 2018;211:114–22.CrossRefPubMed
20.
go back to reference Zang X, Zhang M, Wei S, Tang W, Jiang S. Impact of public hospital pricing reform on medical expenditure structure in Jiangsu, China: a synthetic control analysis. BMC Health Serv Res. 2019;19(1):512.CrossRefPubMedPubMedCentral Zang X, Zhang M, Wei S, Tang W, Jiang S. Impact of public hospital pricing reform on medical expenditure structure in Jiangsu, China: a synthetic control analysis. BMC Health Serv Res. 2019;19(1):512.CrossRefPubMedPubMedCentral
21.
go back to reference Zhu D, Shi X, Chen S, Ye X, He P. Impacts of price changes on public hospital reforms in China: evidence from 25 million patients at tertiary hospitals. Health Policy Plann. 2022;37(10):1210–20.CrossRef Zhu D, Shi X, Chen S, Ye X, He P. Impacts of price changes on public hospital reforms in China: evidence from 25 million patients at tertiary hospitals. Health Policy Plann. 2022;37(10):1210–20.CrossRef
22.
go back to reference Shi L, Yang HY, Cheng G, Meng Q. Time trends and determinants of pharmaceutical expenditure in China (1990–2009). PharmacoEconomics. 2014;32(3):257–64.CrossRefPubMed Shi L, Yang HY, Cheng G, Meng Q. Time trends and determinants of pharmaceutical expenditure in China (1990–2009). PharmacoEconomics. 2014;32(3):257–64.CrossRefPubMed
23.
24.
go back to reference National Health Commission. China National Health Statistical Yearbook 2020. China union medical university press; 2022. National Health Commission. China National Health Statistical Yearbook 2020. China union medical university press; 2022.
25.
go back to reference China National Health Development Research Center. China National Health accounts Report 2020. China National Health Development Research Center; 2020. China National Health Development Research Center. China National Health accounts Report 2020. China National Health Development Research Center; 2020.
27.
go back to reference Pasara MT, Mutambirwa TK, Diko N. The Trivariate Causality among Education, Health, and Economic Growth in Zimbabwe. Sustainability. 2020;12(4). Pasara MT, Mutambirwa TK, Diko N. The Trivariate Causality among Education, Health, and Economic Growth in Zimbabwe. Sustainability. 2020;12(4).
28.
go back to reference Kumar S, Managi S, Matsuda A. Stock prices of clean energy firms, oil and carbon markets: a vector autoregressive analysis. Energy Econ. 2012;34(1):215–26.CrossRef Kumar S, Managi S, Matsuda A. Stock prices of clean energy firms, oil and carbon markets: a vector autoregressive analysis. Energy Econ. 2012;34(1):215–26.CrossRef
29.
go back to reference Yi H, Miller G, Zhang L, Li S, Rozelle S. Intended and unintended consequences of China’s zero markup drug policy. Health Aff. 2015;34(8):1391–8.CrossRef Yi H, Miller G, Zhang L, Li S, Rozelle S. Intended and unintended consequences of China’s zero markup drug policy. Health Aff. 2015;34(8):1391–8.CrossRef
30.
go back to reference Gao L, Shi L, Meng Q, Kong X, Guo M, Lu F. Effect of healthcare system reforms on public hospitals’ revenue structures: evidence from Beijing, China. Soc Sci Med. 2021;283:114210.CrossRefPubMed Gao L, Shi L, Meng Q, Kong X, Guo M, Lu F. Effect of healthcare system reforms on public hospitals’ revenue structures: evidence from Beijing, China. Soc Sci Med. 2021;283:114210.CrossRefPubMed
31.
go back to reference Tang W, Xie J, Lu Y, Liu Q, Malone D, Ma A. Effects on the medical revenue of comprehensive pricing reform in Chinese urban public hospitals after removing drug markups: case of Nanjing. J Med Econ. 2018;21(4):326–39.CrossRefPubMed Tang W, Xie J, Lu Y, Liu Q, Malone D, Ma A. Effects on the medical revenue of comprehensive pricing reform in Chinese urban public hospitals after removing drug markups: case of Nanjing. J Med Econ. 2018;21(4):326–39.CrossRefPubMed
32.
go back to reference Li Y, Xing X, Li C. Dynamic pricing model of medical services in public hospitals in China. Curr Sci. 2015;109(8):1437–44.CrossRef Li Y, Xing X, Li C. Dynamic pricing model of medical services in public hospitals in China. Curr Sci. 2015;109(8):1437–44.CrossRef
33.
go back to reference Lin P and Liu B. The Dynamic Adjustment Mechanism of Medical Service Price [in Chinese]. Health Econ Res. 2019;36(08):20–3. Lin P and Liu B. The Dynamic Adjustment Mechanism of Medical Service Price [in Chinese]. Health Econ Res. 2019;36(08):20–3.
Metadata
Title
Assessing the price levels of medical service and influential factors: evidence from China
Authors
Yanxian Lin
Luo Li
Bao Liu
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2024
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-024-17639-2

Other articles of this Issue 1/2024

BMC Public Health 1/2024 Go to the issue